Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 5.85
-0.01 (-0.09%)
Nov 3, 2025, 2:38 PM CET
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of 23.88 million as of November 3, 2025. Its market cap has decreased by -65.61% in one year.
Market Cap
23.88M
Enterprise Value
38.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.85
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has decreased from 26.85M to 23.88M, a decrease of -11.07%. That is a compound annual growth rate of -1.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 23.88M | -62.96% |
| Dec 30, 2024 | 64.47M | 53.27% |
| Dec 29, 2023 | 42.06M | -18.86% |
| Dec 30, 2022 | 51.84M | -70.44% |
| Dec 30, 2021 | 175.36M | -4.91% |
| Dec 30, 2020 | 184.42M | 226.98% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.24B |
| NEUCA | 3.34B |
| Synektik Spólka Akcyjna | 2.24B |
| Voxel | 1.60B |
| Celon Pharma | 1.16B |
| Selvita | 677.32M |
| Centrum Medyczne ENEL-MED | 511.87M |
| Bioceltix | 477.67M |